Although our community has not responded as it deserved, the contribution from Sanda Boca-Farcau deserves a proper mention from the Chair :)

Dear COSTers,
the slides of all presentations offered during our WG3 workshop  "Advancing cancer nanomedicine to the clinics:
hypes, hopes and hurdles", held in Magdeburg (DE) on June 16-17 are now available for download at the WS dedicated page.
 

Dear COSTers,
the pdf version of the presentations offered during the WG3 Meeting, held March 24-25, 2022 in Bellinzona (CH) are now available for downloading on our website on the dedicated page (Working Group 3/WG3 Meeting, Bellinzona (CH).

Click here to access the page directly. Happy reading!

Standing firm together with scientists from Europe and the world, COST affirms its solidarity with Ukraine and its people. COST will continue to promote scientific activities for peaceful purposes in strong condemnation of war and violence. COST, by providing networking opportunities for researchers and innovators from Europe and beyond, can be a powerful weapon against totalitarianism. Therefore, COST is calling for international efforts to help ensuring the safety of Ukrainian researchers and innovators.

Dear COSTers,

we are pleased to inform you that, thanks to our Action Member Prof. Bruno Sarmento (University of Porto), Elsevier has accepted to launch a special issue of the European Journal of Pharmaceutical Sciences (EJPS) (https://www.journals.elsevier.com/european-journal-of-pharmaceutical-sc…) dedicated to our Action.

EJPS is an Open Access journal, with current IF = 4.384, ranking it 86 out of 275 in Pharmacology & Pharmacy (Q1)

The special issue is entitled "Cancer Nanomedicine: from the bench to the bedside" and  features Prof. Sarmento and the Action Chair (Prof. Sabrina Pricl) as the guest editors.

All submitted papers will receive a 30% discount on the publication fee. Special discount may apply (please see https://www.elsevier.com/journals/european-journal-of-pharmaceutical-sc…)

The Guest Editors decided to welcome also submissions from scientists who are not members of our COST Action. So, please help in spreading the news!

The submission process is already open online on EJPS online platform, and submitting authors just need to follow the link below:

https://www.editorialmanager.com/phasci/default1.aspx

and select the SI “cancer” for being eligible.

Prof. Sarmento and the Action Chair really look forward to receiving your contributions and wish you good work and good luck!